IL6 and metabolic syndrome: In this nested case–control study of Mediterranean individuals with overweight/obesity and MetS, higher baseline concentrations of IL-6, IL-1ra, TNFα, and IL-1β were associated with an increased risk of incident CKD after one-year follow-up.